Post by
livermore2 on Feb 16, 2024 12:04pm
CG Oncology making new highs
Over $3B valuation at $50usd share price. I see CGON as a near valuation peer to TLT should we be successful in BTD.
Good luck
Comment by
enriquesuave on Feb 16, 2024 12:38pm
$3Billion US is $4Billion CAD. So if we were trading at same MC we would be at $12 -13 per share fully diluted. Can we just go up to half on BTD? Would be awesome!
Comment by
enriquesuave on Feb 17, 2024 7:09pm
HC Wainwright gives CGON a $75 dollar SP target. That's $4.5 Billion US not fully diluted! All they have is Bladder cancer on the pipeline. That would be $6 Billion plus CAN . If we had a similar target that would be $20 per share CAN fully diluted. https://www.marketbeat.com/instant-alerts/nasdaq-cgon-initiated-coverage-2024-02-14/
Comment by
riverrrow on Feb 17, 2024 8:54pm
Those of us holding the TLT tradeable warrants would love to see a TLT share price comparable to CGON, preferably before the warrants expire in August. GLTA.
Comment by
Oilminerdeluxe on Feb 18, 2024 1:37am
Quite a breathtaking thing if we were to get a similar valuation. I hope Roger can update us soon on how that pre-BTD thing is going. They money should last a while yet at least. One could at least assume a few bigger companies wanting to partner up when/if we are approved. It appears Roger has a stable of people willing to support the bills while we wait. A big thank you to them.
Comment by
DeathXray33 on Feb 18, 2024 12:31pm
CON-007... I'm sorry, I had too. Lol...
Comment by
Yajne on Feb 18, 2024 11:14am
Need to keep in mind that CGON is traded on the NASDAQ so exposure is much greater. Stocks on Canadian exchanges don't seem to be 'getting the love' from investors over the past several years. Apparently lots of reasons. In light of this, I would be happy with even half of the CGON valuation.
Comment by
chry200030 on Feb 18, 2024 11:53am
CGON not many shares compares to TLT. Will need a reverse split to match.